Fortrea Holdings Inc (FTRE)
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference
Bristol Myers Squibb - Bristol Myers Squibb to Host Hematology-Focused Investor Event
Bristol Myers Squibb to Host Hematology-Focused Investor Event
Bristol Myers Squibb to Host Hematology-Focused Investor Event
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
Enlivex Announces Positive 6-Month Topline Data –Demonstrating Durable and Persistent Pain Reduction and Improved Function in Primary Age-Related Patients with Moderate to Severe Knee Osteoarthritis
Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimers disease progression